APA (7th ed.) Citation

Townsend, W., Leong, S., Shah, M., Batten, T., Tucker, D., Pottinger, B., . . . Jasani, P. (2023). Time Limited Exposure to a ROR1 Targeting Bispecific T Cell Engager (NVG-111) Leads to Durable Responses in Subjects with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). Blood, 142(Supplement 1), 329. https://doi.org/10.1182/blood-2023-188607

Chicago Style (17th ed.) Citation

Townsend, William, et al. "Time Limited Exposure to a ROR1 Targeting Bispecific T Cell Engager (NVG-111) Leads to Durable Responses in Subjects with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)." Blood 142, no. Supplement 1 (2023): 329. https://doi.org/10.1182/blood-2023-188607.

MLA (9th ed.) Citation

Townsend, William, et al. "Time Limited Exposure to a ROR1 Targeting Bispecific T Cell Engager (NVG-111) Leads to Durable Responses in Subjects with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)." Blood, vol. 142, no. Supplement 1, 2023, p. 329, https://doi.org/10.1182/blood-2023-188607.